Lund
Sweden
14
2026-01-29
6
2025-11-04
These are the the leading inventors for applications assigned to Hansa Biopharma AB:
Hansa Biopharma AB based in Lund, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CYSTEINE PROTEASE
#2 | 2026-01-22CONDITIONING REGIMEN FOR CELL TRANSPLANT
#3 | 2026-01-01METHOD FOR IMPROVING THE BENEFIT TO A SUBJECT OF A THERAPY OR THERAPEUTIC AGENT
#4 | 2025-10-23METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES
#5 | 2025-10-02CYSTEINE PROTEASE
#6 | 2024-10-31 ✅ Patent 12,460,194 granted on 2025-11-04CYSTEINE PROTEASE
#7 | 2023-11-09 ✅ Patent 12,359,183 granted on 2025-07-15CYSTEINE PROTEASE
#8 | 2023-07-06CONDITIONING REGIMEN FOR TRANSPLANT
#9 | 2023-06-15METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES
#10 | 2023-04-13IMMUNOGLOBULIN DETECTION AND ASSOCIATED THERAPIES
#11 | 2022-06-02 ✅ Patent 11,667,905 granted on 2023-06-06Cysteine protease
#12 | 2021-08-26 ✅ Patent 12,397,044 granted on 2025-08-26METHOD
#13 | 2020-09-10 ✅ Patent 11,214,784 granted on 2022-01-04Cysteine protease
#14 | 2018-01-25 ✅ Patent 10,696,959 granted on 2020-06-30Cysteine protease
Also check out Hansa BioPharma AB's (Lund, Sweden) applicant profile with 11 patent applications submitted.
335846 ⎘